glp-1 coverage insurers news today Insurance companies scrambling to support need for drugs - Insurance GLP-1 Agonists Market Report 2025-2033,
Description
GLP-1RA drugs were associated with significant benefits to neurological and behavioral health, with reduced risks of seizures and addiction to substances such as alcohol, cannabis, stimulants and opioids
As shown in Scheme 18
However, most people can expect to receive GLP-1 injections on a weekly basis throughout their weight loss journey
The most frequently reported NAEs included dizziness (n = 7,078), tremor (n = 2,519), dysgeusia (n = 1,469), lethargy (n = 783), taste disorder (n = 482), presyncope (n = 370), allodynia (n = 192), and parosmia (n = 192) (Fig
DaviesMJD'AlessioDAFradkinJKernanWNMathieuCMingroneGet al
